病毒免疫逃逸机制
Viral mechanisms of immune evasion.
作者信息
Alcami A, Koszinowski U H
机构信息
The Division of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, UK CB2 1QP.
出版信息
Mol Med Today. 2000 Sep;6(9):365-72. doi: 10.1016/s1357-4310(00)01775-5.
Abstract
During the millions of years they have coexisted with their hosts, viruses have learned how to manipulate host immune control mechanisms. Viral gene functions provide an overview of many relevant principles in cell biology and immunology. Our knowledge of viral gene functions must be integrated into virus-host interaction networks to understand viral pathogenesis, and could lead to new anti-viral strategies and the ability to exploit viral functions as tools in medicine.
摘要
在与宿主共存的数百万年里，病毒学会了如何操纵宿主的免疫控制机制。病毒基因功能概述了细胞生物学和免疫学中的许多相关原理。我们对病毒基因功能的了解必须整合到病毒 - 宿主相互作用网络中，以理解病毒发病机制，这可能会带来新的抗病毒策略，并使我们能够将病毒功能作为医学工具加以利用。
相似文献
1
Viral mechanisms of immune evasion.
Mol Med Today. 2000 Sep;6(9):365-72. doi: 10.1016/s1357-4310(00)01775-5.
2
Viral mechanisms of immune evasion.
Immunol Today. 2000 Sep;21(9):447-55. doi: 10.1016/s0167-5699(00)01699-6.
3
Viral mechanisms of immune evasion.
Trends Microbiol. 2000 Sep;8(9):410-8. doi: 10.1016/s0966-842x(00)01830-8.
4
Viral strategies of immune evasion.
Science. 1998 Apr 10;280(5361):248-53. doi: 10.1126/science.280.5361.248.
5
Subversion and piracy: DNA viruses and immune evasion.
Res Vet Sci. 2001 Jun;70(3):205-19. doi: 10.1053/rvsc.2001.0462.
6
Immunology of viral infections.
Int Ophthalmol Clin. 1985 Summer;25(2):107-16. doi: 10.1097/00004397-198502520-00013.
7
Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.
Immunol Rev. 2010 May;235(1):128-46. doi: 10.1111/j.0105-2896.2010.00909.x.
8
Viral evasion of cytokine-mediated host defense mechanisms.
G Batteriol Virol Immunol. 1994 Jan-Dec;86(1-12):3-10.
9
Immunological aspects of virology. WHO Working Group.
Bull World Health Organ. 1985;63(5):813-20.
10
The interferon antiviral response: from viral invasion to evasion.
Curr Opin Infect Dis. 2002 Jun;15(3):259-67. doi: 10.1097/00001432-200206000-00008.
引用本文的文献
1
Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression?
Npj Viruses. 2024 Sep 2;2(1):41. doi: 10.1038/s44298-024-00051-3.
2
Orthopoxvirus Zoonoses-Do We Still Remember and Are Ready to Fight?
Pathogens. 2023 Feb 21;12(3):363. doi: 10.3390/pathogens12030363.
3
RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein.
Virus Genes. 2023 Apr;59(2):215-222. doi: 10.1007/s11262-022-01958-w. Epub 2022 Nov 21.
4
Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat.
Front Immunol. 2019 Apr 12;10:778. doi: 10.3389/fimmu.2019.00778. eCollection 2019.
5
Analysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset.
Clin Transl Immunology. 2017 Feb 10;6(2):e127. doi: 10.1038/cti.2017.1. eCollection 2017 Feb.
6
Inhibitory effects of human lactoferrin on U14 cervical carcinoma through upregulation of the immune response.
Oncol Lett. 2014 Mar;7(3):820-826. doi: 10.3892/ol.2013.1776. Epub 2013 Dec 27.
7
Neuronal toxicity in HIV CNS disease.
Future Virol. 2012 Jul 1;7(7):687-698. doi: 10.2217/fvl.12.57.
8
SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family.
BMC Res Notes. 2010 Oct 27;3:271. doi: 10.1186/1756-0500-3-271.
9
Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.
Biomaterials. 2009 Apr;30(11):1989-2005. doi: 10.1016/j.biomaterials.2008.11.025. Epub 2009 Jan 29.
10
Molecular decoys: antidotes, therapeutics and immunomodulators.
Curr Opin Biotechnol. 2008 Dec;19(6):644-51. doi: 10.1016/j.copbio.2008.10.001. Epub 2008 Nov 18.
本文引用的文献
1
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.
J Gen Virol. 2000 Oct;81(Pt 10):2341-2364. doi: 10.1099/0022-1317-81-10-2341.
2
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8455-60. doi: 10.1073/pnas.150240097.
3
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8051-6. doi: 10.1073/pnas.140129797.
4
Viral subversion of the immune system.
Annu Rev Immunol. 2000;18:861-926. doi: 10.1146/annurev.immunol.18.1.861.
5
Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
J Immunol. 2000 May 15;164(10):5019-22. doi: 10.4049/jimmunol.164.10.5019.
6
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.
J Virol. 2000 Jun;74(11):5300-9. doi: 10.1128/jvi.74.11.5300-5309.2000.
7
M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes.
J Exp Med. 2000 May 1;191(9):1487-98. doi: 10.1084/jem.191.9.1487.
8
Poxviral mimicry of complement and chemokine system components: what's the end game?
Immunol Today. 2000 May;21(5):242-8. doi: 10.1016/s0167-5699(00)01606-6.
9
Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.
J Immunol. 2000 May 1;164(9):4775-82. doi: 10.4049/jimmunol.164.9.4775.
10
Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins.
J Gen Virol. 2000 May;81(Pt 5):1223-30. doi: 10.1099/0022-1317-81-5-1223.
Zotero 插件